55 Cost Effectiveness Analysis, Sabila Naura Afifa, Fakultas Farmasi UMP, 2022
DAFTAR PUSTAKA
Acton, A (ed.). 2013. Congestive Heart Failure: New Insights for the Healthcare Professional. Scholarly Editions.
Adler, E.D., Goldfinger, J.Z., Kalman, J., Park, M.E., Meier, D.E. 2009. Palliative Care in the Treatment of Advanced Heart Failure, American Heart Association,
Andayani, T. M. 2013. Farmakoekonomi Prinsip Dan Metodologi. Yogyakarta:
Bursa Ilmu.
Arnold R.J.G., 2010. Pharmacoeconomics: from Theory to Practice.USA: Tailor and Francis Group.
Ardiansyah, Muhamad (2012). Medikal bedah untuk mahasiswa. Yogyakarta:
DIVA Pres.
Belien P. 2000. Healthcare Systems. A New European Model. Pharmacoeconomics.
Berger M.L. et al. 2003. Health Care Cost, Quality and Outcomes. ISPOR Book of Terms International Society for Pharmacoeconomic and Outcome Research.
Bootman J. L., Townsend J., dan McGhan. 2001. Principle of Pharmacoconomics.
Third Edition. Harvey Whitney Books Company, Cincinnati. Halaman 93.
Depkes RI, 2008a, Profil Kesehatan Indonesia Indonesia, 2006. Jakarta:
Departemen Kesehatan RI.
Depkes RI, 2008b, Riset Kesehatan Dasar 2007. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan RI.
Depkes RI, 2008c, Modul I Materi Pelatihan Peningkatan Pengetahuan dan Keterampilan Memilih Obat Bagi Tenaga Kesehatan. Jakarta:
Direktorat Jenderal Bina Kefarmasian dan Alat Kesehatan, Departemen Kesehatan RI. Jakarta: Direktorat Jendral Pengendalian Penyakit &
Penyehatan Lingkungan.
56 Cost Effectiveness Analysis, Sabila Naura Afifa, Fakultas Farmasi UMP, 2022
Dipiro, J.T., Wells, B.G., Schwinghammer, T.L., Dipiro, C.V. 2011.
Pharmacotherapy Handbook. 8th Edition. New York: The McGraw- Hill Companies.
Dipiro, J.T., Wells, B.G., Schwinghammer, T.L., Dipiro, C.V. 2011.
Pharmacotherapy Handbook. 9th Edition. New York: The McGraw- Hill Companies.
Donaghue, K. C., Wadwa, R. P., Dimeglio, L. A., Wong, T. Y., Chiarelli, F., Marcovecchio, M. L., Craig, M. E. 2014. “Microvascular and macrovascular complications in children and adolescents”.
Endah, N.S. 2014. Identifikasi Drug Related Problems pada Penatalaksanaan pasien Congestive Heart Failure di Instalasi Rawat Inap Rumah Sakit Umum PKU Muhammadiyah Bantul Yogyakarta, Skripsi, Program Studi Farmasi Fakultas Kedokteran dan Ilmu Kesehatan Universitas Muhammadiyah Yogyakarta, Yogyakarta.
Gerald, K. 1993. American Hospital Formulary Service Drug Information, 271- 450, American Society of Hospital Pharmacist, USA.
Gilman, A. G. 2012. Dasar Farmakologi. Terapi Edisi 10 Volume 2. Jakarta:
Penerbit Buku Kedokteran EGC.
Hadiatussalamah. 2013. Identifikasi Drug Related Problems pada pasien dengan Diagnosa Congestive Heart Failure di Instalasi Rawat Inap Rumah Sakit Umum Dr. Mohammad Hoesin Palembang, Skripsi, Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.
Hawker, J., Begg, N., Blair, I., Reintjes, R. & Weinberg, J. 2005. Communicable Disease Control Handbook, Second Edition, Oxford: Blackwell Science.
Hepler, C.D., dan Strand L.M. 1990. Opportunities and Responsibilities in Pharmaceutical Care. American Journal of Hospital Pharmacy. Vol.
47: 533.
57 Cost Effectiveness Analysis, Sabila Naura Afifa, Fakultas Farmasi UMP, 2022
ISPOR. (2013). Biaya Pelayanan Kesehatan, Kualitas, dan Hasil Akhir. Buku Terminologi ISPOR. Depok: ISPOR Indonesia Chapter.
Jackson, E. K. 2012. Renin dan Angiotensin. Dalam G. A. Gilman, Dasar Farmakologi Terapi, Edisi 10, Volume 2. Jakarta: Penerbit Buku Kedokteran EGC.
Lenander,C., Elfsson,B., Danielsson,B., Midlov,P., Hasselstrom,J., 2014, Effects Of A Pharmacist-led Structured Medication Review In Primary Care On Drug-Related Problems And Hospital Admission Rates: A Randomized Controlled Trial, Scandinavian journal of primary health care, Vol (32): 180-186.
Mentz, R. J., Kelly, J. P., Lueder, T. G. 2014. Noncardiac Comorbidities in Heart Failure with Reduced Versus Preserved Ejection Fraction. Journal of The American College of Cardiology. 64 (21): 2281 – 2293.
Nasir, Abd, Abdul M., Ideputri. 2011. Metodologi Penelitian Kesehatan.
Yogyakarta: Nuha Medika.Halaman 196, 199-200.
National Institute for Health and Care Excellence. 2010. Chronic Heart Failure : Management of Chronic Heart failure in Adults in Primary and Secondary Care.
Nursyafrisda. (2012). Analisis Efektivitas Biaya Penggunaan Ceftriaxone dan Cefotaxime Pada Pasien Pneumonia Balita Di Rawat Inap RSU Kab.
Tangerang Tahun 2010. Tesis Fakultas Kesehatan Masyarakat Universitas Indonesia.
Notoatmodjo, S (2018). Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta.
Powers, B. J., & etal. (2012). Updated Report on Comparative Effectiveness of ACE-Inhibitors, ARBs, and Direct Renin Inhibitors For Patients With Essential Hypertension: much more data, little new information. J Gen Intern Med. 27(6).
58 Cost Effectiveness Analysis, Sabila Naura Afifa, Fakultas Farmasi UMP, 2022
Rascati, K. L., & Wilson, J. P. (2007). Pharmacoeconomics. Dalam P. M. Malone, K. L. Kier, & J. E. Stanovich, Drug Information: A Guide For Pharmacists, 3rd Edition. The McGraw-Hill Companies.
Rustiani, E., Andrajati, R., & Arsyanti, L. 2014. Analisis Penggunaan Obat Antihipertensi di Poliklinik Rawat Jalan Rumah Sakit PMI Bogor:
Perbandingan Cost Effectiveness dan Kualitas Hidup Pasien. Jurnal Ilmu Kefarmasian Indonesia, 209-215.
Santoso, I., Efi, A.R., Rahmatillah, D.R. 2015. Case Report : Drug Related Problem (DRP) Associated with the Treatment of Congestive Heart Failure (CHF) in PGI Cikini Hospital, International Journal of Pharmacy Teaching & Practices (IJPTP).
Syafrida. 2018. Drug Related Problems Pada Terapi Penderita Gagal Jantung Kongestif di RSUD DR. Pirngadi Medan. Skripsi. Fakultas Farmasi.
Universitas Sumatera Utara.
